mutation
- Reports
Emirates Pharmaceutical Company approves the innovative “Etkamah” to treat breast cancer associated with ESR1 mutation
The Emirates Pharmaceutical Corporation announced the approval of the drug “Itkamah”. (Etcamah) “From AstraZeneca, which is an oral treatment directed…
Read More » - Health & Women
Food and Drug Administration approves a new treatment for advanced breast cancer linked to a genetic mutation
The Saudi Food and Drug Authority has approved the registration of Etkamah preparation “Kamizstrant” for the treatment of adult patients…
Read More »


